Lehrstuhl für Geburtshilfe und Frauenheilkunde

Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival (2021) Slamon DJ, Neven P, Chia S, Jerusalem G, De Laurentiis M, Im S, Petrakova K, et al. Journal article Association of prenatal alcohol exposure and prenatal maternal depression with offspring low-grade inflammation in early adolescence (2021) Maschke J, Roetner J, Bösl S, Plank AC, Rohleder N, Goecke TW, Fasching P, et al. Journal article Utility of the CPS + EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy (2021) Marmé F, Solbach C, Michel L, Schneeweiss A, Blohmer JU, Huober J, Fasching P, et al. Journal article Evaluation of integrated hpv dna as individualized biomarkers for the detection of recurrent cin2/3 during post-treatment surveillance (2021) Hoyer H, Mehlhorn G, Scheungraber C, Hagemann I, Hirchenhain C, Woelber L, Stolte C, et al. Journal article Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials (2021) Furlanetto J, Marmé F, Seiler S, Thode C, Untch M, Schmatloch S, Schneeweiss A, et al. Journal article Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis (2021) Gelmon KA, Fasching P, Couch FJ, Balmaña J, Delaloge S, Labidi-Galy I, Bennett J, et al. Journal article Complementary and alternative medicine (CAM) in women with endometriosis (2021) Adamietz A, Boosz A, Mueller A, Hornung D, Trunk K, Beckmann M, Dittrich R, Hack C Journal article Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy (2021) Reimann H, Nguyen A, Sanborn JZ, Vaske CJ, Benz SC, Niazi K, Rabizadeh S, et al. Journal article The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents (2021) Dürr P, Schlichtig K, Kelz C, Deutsch B, Maas R, Eckart MJ, Wilke J, et al. Journal article Bladder tumor subtype commitment occurs in carcinoma in-situ driven by key signaling pathways including ECM remodeling (2021) Wullweber A, Strick R, Lange F, Sikic D, Taubert H, Wach S, Wullich B, et al. Conference contribution